Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.

Microbiology spectrum - 5 Mar 2024

Prommi Ajala, Wongjarit Kanphai, Petsong Suthidee, Somsukpiroh Ubonwan, Faksri Kiatichai, Kawkitinarong Kamon, Payungporn Sunchai, Rotcheewaphan Suwatchareeporn

Abstract excerpt

Isoniazid-resistant tuberculosis (Hr-TB) is an important drug-resistant tuberculosis (TB). In addition to rifampicin, resistance to other medications for Hr-TB can impact the course of treatment; however, there are currently limited data in the literature. In this study, the drug susceptibility profiles of Hr-TB treatment and resistance-conferring mutations were investigated for Hr-TB clinical isolates from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ethambutol
Share to Isoniazid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Levofloxacin

Share to Pyrazinamide

Share to Rifampin

Share to Tertiary Care Centers

Share to Thailand

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 38323824
DOI: 10.1128/spectrum.03462-23
PMCID: PMC10913473

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.PMID 38323824Read ↗

Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.Semantic proximity Read ↗

Isoniazid-resistant tuberculosis: a cause for concern?Semantic proximity Read ↗

Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.Semantic proximity Read ↗

Genotypic and phenotypic drug-resistance detection and prevalence of heteroresistance in patients with isoniazid- and multidrug-resistant tuberculosis in EthiopiaSemantic proximity Read ↗

Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of Mycobacterium tuberculosis isolates from China.Semantic proximity Read ↗

Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China.Semantic proximity Read ↗

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016Semantic proximity Read ↗

Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives.Semantic proximity Read ↗

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.Semantic proximity Read ↗

Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Drug Resistance: A Retrospective Observational Study in Eastern ChinaSemantic proximity Read ↗

Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.Semantic proximity Read ↗

Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.